Immunogenicity persistence in children of hepatitis A vaccines Healive® and Havrix®: 11 years follow-up and long-term prediction

Immunogenicity persistence in children of hepatitis A vaccines Healive® and Havrix®: 11 years follow-up and long-term prediction

Background: Hepatitis A vaccine has been used in mass and routine public vaccination programs in China. Long-term follow-up studies are required to determine the duration of protection and the need for booster vaccinations. Methods: A prospective, randomized, open-label clinical trial was performed...

Full description

Bibliographic Details
Main Authors: Yongji Wang, Yangyang Qi, Wenguo Xu, Yuansheng Hu, Ling Wang, Yongpei Yu, Zhiwei Jiang, Jielai Xia, Gang Zeng, Yalong Wang
Format: Article
Language:English
Published: Taylor & Francis Group 2020-10-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
hepatitis a
vaccine
persistence
seroprotection
long term
immunogenicity
Online Access:http://dx.doi.org/10.1080/21645515.2020.1715687

Similar Items

Similar Items